Related Experiment Videos

Binding ability of complement receptor CR1 to C3 bound on the surface of M+ group A streptococci

K Hong1, T Harada, T Nishimura

  • 1Department of Bacteriology, Osaka University Medical School, Japan.

Immunology
|December 1, 1993
PubMed

Insights

Complement-coated bacteria (M+ bacteria) can adhere to polymorphonuclear leucocytes (PMN) via complement receptor CR1. However, specific C3 deposition patterns in normal human plasma may enhance M+ bacteria's anti-phagocytic activity.

Area of Science:

  • Immunology
  • Microbiology

Background:

  • Previous studies showed M+ bacteria bind complement component 3 (C3) but resist phagocytosis by polymorphonuclear leucocytes (PMN).
  • The mechanism behind this resistance, whether it's poor adherence or impaired C3-receptor interaction, was unclear.

Purpose of the Study:

  • To investigate the interaction between C3-coated M+ bacteria and complement receptor CR1 (CR1) on PMN.
  • To determine if C3 deposited on M+ bacteria can interact with PMN complement receptors.
  • To analyze the distribution of C3 on M+ bacteria in different human serum/plasma conditions and its effect on anti-phagocytic activity.

Main Methods:

  • Studied the interaction of C3-coated M+ bacteria with isolated human erythrocyte CR1.
  • Investigated C3 fragment release from M+ bacteria-bound C3 using factor I and liquid-phase CR1.
  • Analyzed C3 deposition patterns on M+ bacteria in normal human serum (NHS) and normal human plasma (NHP) using immunofluorescence.

Main Results:

  • Isolated CR1 associated with both C3-coated M+ and M- bacteria.
  • C3 on M+ bacteria was cleaved, releasing C3 fragments in the presence of factor I and CR1, suggesting adherence promotion.
  • Immunofluorescence revealed uniform C3 deposition in NHS, but end-specific deposition in NHP, correlating with enhanced anti-phagocytic activity.

Conclusions:

  • Bound C3 on M+ bacteria can facilitate adherence to PMN via CR1.
  • NHP contains a factor that alters C3 deposition, potentially enhancing the anti-phagocytic properties of M+ bacteria.

Related Concept Videos